These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Portal hypertension and hepatocellular carcinoma in patients with alcoholic cirrhosis]. Bataille C; Bercoff E; Lebrec D Acta Gastroenterol Belg; 1983; 46(1-2):18-20. PubMed ID: 6316702 [No Abstract] [Full Text] [Related]
24. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Lebrec D; De Fleury P; Rueff B; Nahum H; Benhamou JP Gastroenterology; 1980 Dec; 79(6):1139-44. PubMed ID: 6969201 [TBL] [Abstract][Full Text] [Related]
25. [Cirrhotic cardiomyopathy: prolonged QTc-interval and dyssynchronic electrical and mechanical systole in cirrhosis]. Henriksen JH; Fuglsang S; Bendtsen F; Christensen E; Møller S Ugeskr Laeger; 2004 Aug; 166(35):2995-8. PubMed ID: 15387011 [No Abstract] [Full Text] [Related]
26. [Detection of umbilical vein repatency by Doppler ultrasonics in portal hypertension caused by alcoholic cirrhosis]. Duvauferrier R; Lucas J; Bellossi A; Bretagne JF; Gastard J Gastroenterol Clin Biol; 1979; 3(8-9):695. PubMed ID: 510864 [No Abstract] [Full Text] [Related]
27. [Correlation between hemodynamic parameters of the portal circulation in cirrhotic patients]. Bretagne JF; Bourguet P; Morisot D; Duvauferrier R; Darnault P; Gastard J Gastroenterol Clin Biol; 1985 Oct; 9(10):674-8. PubMed ID: 4065489 [TBL] [Abstract][Full Text] [Related]
28. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis]. Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D Gastroenterol Clin Biol; 1992; 16(8-9):680-6. PubMed ID: 1426824 [TBL] [Abstract][Full Text] [Related]
29. Clonidine induced endothelium-dependent tonic contraction in circular muscle of the rat hepatic portal vein. Shimamura K; Toba M; Kimura S; Ohashi A; Kitamura K J Smooth Muscle Res; 2006 Jun; 42(2-3):63-74. PubMed ID: 17001113 [TBL] [Abstract][Full Text] [Related]
30. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension. Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A Digestion; 1985; 32(2):92-8. PubMed ID: 2864299 [TBL] [Abstract][Full Text] [Related]
31. Isosorbide dinitrate in portal hypertensive patients. Vorobioff J; Picabea E; Gamen M; Villavicencio R J Hepatol; 1992 Nov; 16(3):387. PubMed ID: 1487620 [No Abstract] [Full Text] [Related]
32. Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure. Taourel P; Blanc P; Dauzat M; Chabre M; Pradel J; Gallix B; Larrey D; Bruel JM Hepatology; 1998 Oct; 28(4):932-6. PubMed ID: 9755228 [TBL] [Abstract][Full Text] [Related]
33. The pathophysiology of portal hypertension: a basis for classification. Groszmann RJ; Atterbury CE Semin Liver Dis; 1982 Aug; 2(3):177-86. PubMed ID: 7178896 [No Abstract] [Full Text] [Related]
34. Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis. Kim MY; Baik SK; Yea CJ; Lee IY; Kim HJ; Park KW; Kim HK; Suk KT; Kim JW; Kim HS; Kwon SO; Cha SH; Kim YJ; Koh SB; Chang SJ Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1241-6. PubMed ID: 19455045 [TBL] [Abstract][Full Text] [Related]
35. Propranolol: its role in the management of portal hypertension. The ACG Committee on FDA related matters. Gitlin N Am J Gastroenterol; 1983 Feb; 78(2):124-6. PubMed ID: 6823937 [No Abstract] [Full Text] [Related]
36. Hypothyroidism Enhanced Portal Hypertension in a Patient with Alcoholic Liver Cirrhosis, Resulting in the Development of Ascites. Kakisaka K; Endo K; Suzuki A; Hayashi S; Abe T; Yoshida Y; Oikawa T; Miyamoto Y; Sawara K; Ishida K; Kuroda H; Takikawa Y Intern Med; 2015; 54(18):2327-31. PubMed ID: 26370856 [TBL] [Abstract][Full Text] [Related]
37. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Lemoine M; Katsahian S; Ziol M; Nahon P; Ganne-Carrie N; Kazemi F; Grando-Lemaire V; Trinchet JC; Beaugrand M Aliment Pharmacol Ther; 2008 Nov; 28(9):1102-10. PubMed ID: 18691352 [TBL] [Abstract][Full Text] [Related]